Lemaitre Vascular (LMAT) Capital Expenditures (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Capital Expenditures data on file, last reported at $2.8 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 101.23% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 17.32% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, down 2.57% from the prior year.
• Capital Expenditures for Q1 2026 stood at $2.8 million, up from $1.8 million in the prior quarter.
• Over the last five years, Capital Expenditures for LMAT reached as high as $2.8 million in Q2 2023 and fell as low as $460000.0 in Q3 2022.
• Historically, Capital Expenditures has averaged $1.6 million across 5 years, with a median of $1.4 million in 2025.
• Across the five-year window, Capital Expenditures slumped 74.64% in 2022 and jumped 297.39% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at $1.3 million in 2022, then advanced by 1.51% to $1.3 million in 2023, then jumped by 59.81% to $2.0 million in 2024, then fell by 13.06% to $1.8 million in 2025, then soared by 56.61% to $2.8 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $2.8 million in Q1 2026, $1.8 million in Q4 2025, and $2.3 million in Q3 2025.